WuXi XDC Cayman, Inc. (HK:2268) has released an update.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
WuXi XDC Cayman Inc. successfully passed a resolution at its extraordinary general meeting on October 25, 2024, to approve revised service fees under its Antibodies Master Services Agreement. Shareholders voted overwhelmingly in favor, with 100% support from eligible voters, excluding certain abstentions from key stakeholders. This decision paves the way for significant financial transactions amounting to RMB2,000 million for each of the next two years.
For further insights into HK:2268 stock, check out TipRanks’ Stock Analysis page.